Advertisement

Möglichkeiten der Wirkungsbeeinflussung von Relaxanzien

  • A. Doenicke
  • B. Grote
Part of the Klinische Anästhesiologie und Intensivtherapie book series (KAI, volume 22)

Zusammenfassung

Das Thema schließt so zahlreiche Möglichkeiten der Wirkungsbeeinflussung ein, daß wir uns entschlossen haben, eine Zweiteilung des Beitrages vorzunehmen. Im ersten Teil werden wir vorwiegend die nichtdepolarisierenden und im zweiten nur die depolarisierenden Muskelrelaxanzien besprechen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    BETTSCHART, A., SCOGNAMIGLIO, W., BOVET, D.: Potenziamento degli effetti della succinilcolina ad opera del ß-dietil-amminoetildifenilpropilacetato (SKF 525-A). Contributo alio studio del meccanismo delie apnee prolungate provocate dalla succinilcolina. R. C. 1st. sup. Sanita 19, 721 (1956)Google Scholar
  2. 2.
    CRUMRINE, R. S., YODLOWSKI, E. H.: Assessment of neuromuscular function in the newborn. Abstracts of scientific papers. ASA’S Annual Meeting, p. 379, 1978Google Scholar
  3. 3.
    DOENICKE, A.: Postoperative apnea caused by abnormal metabolism of muscle relaxants or muscle diseases. Proc. V. World Congr. Anaesthesiologists Kyoto, p. 64. Amsterdam: Excerpta Medica 1972Google Scholar
  4. 4.
    DOENICKE, A.: PseudoCholinesterasen. In: Handbuch der Inneren Medizin, Bd. VII, 7. Aufl., p. 761. Berlin, Heidelberg, New York: Springer 1974Google Scholar
  5. 5.
    DOENICKE, A., GÜRTNER, TH., KREUTZBERG, G., REMES, J., SPIESS, W., STEINBEREITHNER, K.: Serum Cholinesterase an-enzymia. Acta anaesth. scand. 7, 59 (1963)PubMedCrossRefGoogle Scholar
  6. 6.
    DOENICKE, A., HOLLE, F., FREY, H.-H.: Praktische Bedeutung der Plasmacholinesterase-Bestimmung und ihres atypischen Verhaltens gegenüber Succinylbischolin. Anaesthesist 11, 146 (1962)PubMedGoogle Scholar
  7. 7.
    DOENICKE, A., KRUMEY, J., KUGLER, J., KLEMPA, J.: Experimental studies of the breakdown of epontol: determination of propanidid in human serum. Brit. J. Anaesth. 40, 415 (1968)PubMedCrossRefGoogle Scholar
  8. 8.
    DOENICKE, A., SCHMIDINGER, ST., KRUMEY, J.: Suxamethonium and serum Cholinesterase. Brit. J. Anaesth. 40, 834 (1968)PubMedCrossRefGoogle Scholar
  9. 9.
    FEINGOLD, A.: Pancuronium requirements of the morbidly obese. Anesthesiology 50, 269 (1979)PubMedCrossRefGoogle Scholar
  10. 10.
    FOLDES, F. F.: Muscle relaxants in anesthesiology. Springfield/Illinois: Charles C. Thomas 1957Google Scholar
  11. 11.
    FOLDES, F. F., SWERDLOW, M., LIPSCHITZ, E., VAN HEES, G. R., SHANOR, S. P.: Comparison of the respiratory effects of suxamethonium and suxethonium in man. Anesthesiology 17, 559 (1956)PubMedCrossRefGoogle Scholar
  12. 12.
    FORBES, A. R., COHEN, N. H., EGER, E.: Pancuronium reduces halothane requirements in man. Anesth. Analg. 58, 4 97 (1979)Google Scholar
  13. 13.
    GHONEIM, M. M., PANDYA, H.: Binding of tubocurarine to specific serum protein fractions. Brit. J. Anaesth. 47, 853 (1975)PubMedCrossRefGoogle Scholar
  14. 14.
    GOEDDE, H. W., DOENICKE, A., ALTLAND, K.: Pseudocholinester-asen — Pharmakokinetik — Biochemie — Klinik. Berlin, Heidelberg, New York: Springer 1967Google Scholar
  15. 15.
    GÜRTNER, TH., KREUTZBERG, G., DOENICKE, A.: Comparative studies on Cholinesterase activity in serum and in liver cells. Acta anaesth. scand. 7, 69 (1963)PubMedCrossRefGoogle Scholar
  16. 16.
    HAM, J., MILLER, R. D., BENET, L. Z., MATTEO, R. S., RODERICK, L. L.: Pharmacokinetics and pharmacodynamics of d-tubo-curarine during hypothermia in the cat. Anesthesiology 49, 324 (1978)PubMedCrossRefGoogle Scholar
  17. 17.
    HAUPT, H., HEIDE, K., ZWISLER, O., SCHICK, H. G.: Isolierung und physikalisch-chemische Charakterisierung der Cholinesterase aus Human serum. Blut 14, 65 (1966)PubMedCrossRefGoogle Scholar
  18. 18.
    HAZEL, B., MONIER, D.: Human serum Cholinesterase: variations during pregnancy and postpartum. Canad. Anaesth. Soc. J. 18, 272 (1971)PubMedCrossRefGoogle Scholar
  19. 19.
    HOLST-LARSEN, H.: The hydrolysis of suxamethonium in human blood. Brit. J. Anaesth. 48, 887 (1976)PubMedCrossRefGoogle Scholar
  20. 20.
    KALOW, W.: The distribution and elimination of muscle relaxants. Anesthesiology 20, 505 (1959)PubMedCrossRefGoogle Scholar
  21. 21.
    KALOW, W., GENEST, K.: A method for the detection of atypical forms of human serum Cholinesterase. Determination of dibucaine numbers. Canad. J. Biochem. Physiol. 35, 339 (1957)PubMedCrossRefGoogle Scholar
  22. 22.
    KELLY, S. S., ROBERTS, D. V.: The effect of age on the safety-factor in neuromuscular transmission in the isolated diaphragm of the rat. Brit. J. Anaesth. 49, 217 (1977)PubMedCrossRefGoogle Scholar
  23. 23.
    KONCHIGERI, H. N., TUMMURU, K. R.: Pretreatment with non-depolarizing muscle relaxants and dosage of succinylcholine. Anesthesiology 51, S 276 (1979)CrossRefGoogle Scholar
  24. 24.
    KUCHER, R.: Einfluß der Unterkühlung auf die Wirkung von Mus-kelrelaxantien. 2. Fortbildungskurs f. klin. Anaesthesiolo-gen, Wien, p. 2, 1965Google Scholar
  25. 25.
    MEIJER, D. K. F., WEITERING, J. G., VERMEER, G. A., SCAF, A. H. J.: Comparative pharmacokinetics of d-tubocurarine and metocurine in man. Anesthesiology 51, 402 (1979)PubMedCrossRefGoogle Scholar
  26. 26.
    MILLER, R. D., EGER, E. I.: Early and late relative potencies of pancuronium and d-tubocurarine in man. Anesthesiology 44, 297 (1976)PubMedCrossRefGoogle Scholar
  27. 27.
    MILLER, R. D., RODERICK, L. L.: Diuretic-induced hypokal-aemia, pancuronium neuromuscular blockade and its antagonism by neostigmine. Brit. J. Anaesth. 50, 541 (1978)PubMedCrossRefGoogle Scholar
  28. 28.
    MILLER, R. D., SOHN, Y. J., MATTEO, R. S.: Enhancement of d-tubocurarine neuromuscular blockade by diuretics in man. Anesthesiology 45, 442 (1976)PubMedCrossRefGoogle Scholar
  29. 29.
    O’KEEFFE, C. O., GREGORY, G. A., STANSKI, D. R., MILLER, R. D.: D-tubocurarine: pharmacodynamics and kinetics in children. Anesthesiology 51, 270 (1979)CrossRefGoogle Scholar
  30. 30.
    PITTINGER, CH. B., ERYASA, Y., ADAMSON, R.: Antibiotic induced paralysis. Anesth. Analg. 49, 487 (1970)PubMedGoogle Scholar
  31. 31.
    SCHMIDINGER, ST., HELD, K. R., GOEDDE, H. W.: Hydrolysis of succinyldicholine by pseudoCholinesterase at low concentrations. Humangenetik 2, 221 (1966)PubMedCrossRefGoogle Scholar
  32. 32.
    SCHUH, F. T.: Zur Cholinesterase-Hemmung durch Pancuronium. Anaesthesist 26, 125 (1977)PubMedGoogle Scholar
  33. 33.
    STANSKI, D. R., HAM, J., MILLER, R. D., SHEINER, L. B.: Pharmacokinetics and pharmacodynamics of d-tubocurarine during nitrous oxide-narcotic and halothane anesthesia in man. Anesthesiology 51, 235 (1979)PubMedCrossRefGoogle Scholar
  34. 34.
    STANSKI, D. R., HAM, J., MILLER, R. D., SHEINER, L. B.: Time dependent increase in sensitivity to dtc during enflurane anesthesia. Anesthesiology 51, 269 (1979)CrossRefGoogle Scholar
  35. 35.
    THOMPSON, J. M.: Pancuronium binding by serum proteins. Anaesthesia 31, 219 (1976)PubMedCrossRefGoogle Scholar
  36. 36.
    WASER, P. G., LÜTHI, U.: Verteilung, Metabolismus und Elimination von 3n-Diallyl-nor-Toxiferin (Alloferin) bei Katzen. Helv. physiol. Acta 24, 259 (1966)Google Scholar
  37. 37.
    WAUD, B. E.: Decrease in dose requirement of d-tubocurarine by volatile anesthetics. Anesthesiology 51, 298 (1979)PubMedCrossRefGoogle Scholar
  38. 38.
    WHITTAKER, M.: Plasma Cholinesterase variants and the anaesthetist. Anaesthesia 35, 174 (1980)PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1980

Authors and Affiliations

  • A. Doenicke
  • B. Grote

There are no affiliations available

Personalised recommendations